Bone Metabolism Parameters in Azerbaijani Pre and Postmenopausal Women with Diabetes
Abstract
Background: This study aimed to determine the directionality of changes in serum bone remodeling markers and bone mineral density in the pre- and postmenopausal women with diabetes mellitus.
Methods: This study was carried out during the years 2016–2017 on the basis of Azerbaijan Medical University and included 142 pre- and postmenopausal women with type 1 and 2 diabetes mellitus (DM 1and DM2) were compared with 43 age-matched non-diabetics. The groups evaluated Ca2+, PTH, CT, 25(OH)D levels, serum bone remodeling markers (ALP, P1NP, b-CTx), lumbar spine, proximal and femoral neck areas using DXA assessment.
Results: The results showed inconsistency observed between bone remodeling processes in women with diabetes. A negative correlation was observed between duration of diabetes and Lumbar T-scores (DM1: r = -0.568, P = 0.001; DM2: r = -0.267, P = 0.04). Lumbar T-scores was negatively correlated with b-CTx level (DM1: r = -0.452, P = 0.002; DM2: r = -0.357, P = 0.09). Postmenopausal groups with DM1 and DM2 were slightly higher b-CTx levels than premenopausal.
Conclusion: The patients with DM2 compared to DM1 had higher average BMD at all measured areas. Bone fragility is the result not so much of a decrease in BMD, but alterations in bone microstructure, as indicated by the disregulation of bone remodeling markers. This suggests that patients with diabetes are at a higher risk of bone turnover disorders compared to individuals without diabetes, which does not necessarily correlate with differences in BMD.
2. Vestergaard P, Rejnmark L, Mosekilde L (2009). Diabetes and its complications and their relationship with risk of frac-tures in type 1 and 2 diabetes. Calcif Tissue Int, 84 (1): 45-55.
3. International Diabetes Federation, IDF Dia-betes Atlas, International Diabetes Feder-ation, Brussels, Belgium, 8th edition (2017). http://www.diabetesatlas.org
4. Farr JN, Khosla S (2016). Determinants of bone strength and quality in diabetes mellitus in humans. Bone, 82: 28-34.
5. Khan TS, Fraser LA (2015). Type 1 diabetes and osteoporosis: from molecular path-ways to bone phenotype. J Osteoporos, 2015: 174186.
6. Al-Hariri M (2016). Sweet bones: the patho-genesis of bone alteration in diabetes. J Diabetes Res, 2016: 6969040.
7. Safarova S (2018). Evaluation of bone turn-over in patients with type 1 diabetes mellitus. J Endocrinol Metab, 8 (1): 2-5.
8. Ghodsi M, Larijani B, Keshtkar AA, et al (2016). Mechanisms involved in altered bone metabolism in diabetes: a narrative review. J Diabetes Metab Disord, 15: 52.
9. Juliana S Cunha, Vanessa M Ferreira, Edgar Maquigussa, et al (2014). Effects of high glucose and high insulin concentrations on osteoblast function in vitro. Cell Tissue Res, 358 (1): 249-256.
10. Starup-Linde J, Vestergaard P (2016). Bio-chemical bone turnover markers in diabe-tes mellitus-a systematic review. Bone, 82: 69-78.
Files | ||
Issue | Vol 52 No 2 (2023) | |
Section | Original Article(s) | |
DOI | https://doi.org/10.18502/ijph.v52i2.11886 | |
Keywords | ||
Diabetes mellitus Menopause Bone |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |